Bioventix PLC (AIM:BVXP)
London · Delayed Price · Currency is GBP · Price in GBX 1,750.00
0.00 (0.00%)
Feb 12, 2026, 4:35 PM GMT
Bioventix Market Cap
Bioventix has a market cap or net worth of 91.44 million as of February 12, 2026. Its market cap has decreased by -45.26% in one year.
Market Cap
91.44M
Enterprise Value
86.36M
Revenue
13.12M
Ranking
n/a
PE Ratio
12.21
Stock Price
1,750.00
Market Cap Chart
Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 91.44M, an increase of 828.51%. That is a compound annual growth rate of 15.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 91.44M | -8.14% |
| Dec 31, 2025 | 99.53M | -39.94% |
| Dec 31, 2024 | 165.72M | -26.16% |
| Dec 29, 2023 | 224.45M | 7.98% |
| Dec 30, 2022 | 207.85M | 17.35% |
| Dec 31, 2021 | 177.12M | -22.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avacta Group | 264.63M |
| Faron Pharmaceuticals Oy | 193.94M |
| Scancell Holdings | 134.91M |
| 4basebio | 86.67M |
| Hemogenyx Pharmaceuticals | 66.45M |
| SkinBioTherapeutics | 52.43M |
| hVIVO | 41.50M |
| Ondine Biomedical | 39.98M |